Bank of America reaffirmed its Buy rating for Eli Lilly, setting a price target of $1,268. Analyst Jason Gerberry noted that the trial data strengthens the company's competitive stance against rival ...
Scripps News on MSN
White House announces more deals to bring down prescription drug prices
The White House announced new agreements with nine pharmaceutical companies to lower prescription drug prices Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback